Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
06/12/2008 | WO2008017361A3 2-(heterocyclylbenzyl)pyridazinone derivatives |
06/12/2008 | WO2008015517A3 Ep2 agonists |
06/12/2008 | WO2008000483A3 Phenol derivatives for the treatment of respiratory diseases |
06/12/2008 | WO2007083187A3 An improved process for the preparation of monobactam antibiotic |
06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
06/12/2008 | US20080139627 Heterocyclic amide and imine derivatives, processes for their preparation, compositions comprising them and their use as pesticides |
06/12/2008 | US20080139616 Atherosclerosis; inflammatory diseases, Alzheimer's disease, dyslipidemia, metabolic syndrome; 2-isopropyl-5-phenyl-4-[(4-phenylbutyl)amino]isothiazole-3(2H)-thione 1,1-dioxide for example |
06/12/2008 | US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives |
06/12/2008 | US20080139560 Ion Channel Modulators |
06/12/2008 | US20080139536 Benzodiazepines for Treating or Preventing Rsv Infection |
06/12/2008 | US20080139535 1-(2-naphthylsulfonyl)-4-(5-hydroxyaminocarbonylthiazol-2-yl)piperazine; antiproliferative agent; cell cycle arrest, cellular differentiation, apoptosis and reversal of the transformed phenotype; |
06/12/2008 | US20080139530 7-Aryl 1,5-Dihydro-4,1-Benzoxazepin-2(3H)-One Derivatives And Their Use As Progesterone Receptor Modulators |
06/12/2008 | US20080139390 Isoxazoline Derivatives and Their Use as Herbicides |
06/12/2008 | US20080138740 Cyanine Compound, Optical Recording Material Using the Same and Optical Recording Medium |
06/12/2008 | US20080134448 vivid color to hair without causing decomposition of the direct azo dye; excellent fastness to light, wash, sweat, friction and heat; stable to alkalizing agents and oxidizing agents; 4-azo-2,1,3-BENZOTHIADIAZOLE dyes |
06/12/2008 | CA2671990A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
06/12/2008 | CA2670870A1 Antibacterial polycyclic urea compounds |
06/12/2008 | CA2669829A1 Antibacterial quinoline derivatives |
06/12/2008 | CA2669819A1 Antibacterial quinoline derivatives |
06/12/2008 | CA2668558A1 Antibacterial quinoline derivatives |
06/11/2008 | EP1930319A1 Proline derivatives and use thereof as drugs |
06/11/2008 | EP1928872A1 Novel sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles |
06/11/2008 | EP1928871A2 Bicyclic derivatives as modulators of voltage gated ion channels |
06/11/2008 | EP1928870A1 Chemical process for the preparation of benzoxazole derivatives used as pesticides |
06/11/2008 | EP1928869A1 Chemical process |
06/11/2008 | EP1928868A1 Iminooxazolidine derivatives and use thereof |
06/11/2008 | EP1928865A1 Novel high affinity thiophene-based and furan-based kinase ligands |
06/11/2008 | EP1928861A1 4- (ih-indazol-s-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer |
06/11/2008 | EP1928843A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseaes |
06/11/2008 | EP1928508A1 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents |
06/11/2008 | EP1928243A2 Thiazoles used as fungicides |
06/11/2008 | EP1727809B1 Substituted morpholine and thiomorpholine derivatives |
06/11/2008 | EP1368032B1 Excitatory amino acid receptor antagonists |
06/11/2008 | EP1255739B1 3-aminoquinazolin-2,4-dione antibacterial agents |
06/11/2008 | CN101198605A N-(pyridin-2-yl)-sulfonamide derivatives |
06/11/2008 | CN101198604A NPY antagonists, preparation and use |
06/11/2008 | CN101198603A 4-(pyrid-2-yl) amino substituted pyrimidine as protein kinase inhibitors |
06/11/2008 | CN101198596A 2-amino-quinaz0lin-5-ones as HSP90 inhibitors useful in treating proliferation diseases |
06/11/2008 | CN101195618A Method for producing beta crystal system anhydrous aztreonam |
06/11/2008 | CN101195617A 2-thiazolyl-3-pyridinyl vinyl cyanide compounds and production and application thereof |
06/11/2008 | CN100393718C Thiazole derivatives as npy antagonists |
06/11/2008 | CN100393714C Gyrase inhibitors and uses thereof |
06/11/2008 | CN100393713C Therapeutic agents useful for treating pain |
06/10/2008 | US7385063 Method for preparing imidazole derivatives |
06/10/2008 | US7384967 Aryl carbonyl derivatives as therapeutic agents |
06/10/2008 | US7384965 Fused heterocyclic derivatives as PPAR modulators |
06/10/2008 | US7384964 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
06/10/2008 | US7384958 Quinoline inhibitors of cGMP phosphodiesterase |
06/10/2008 | US7384933 Derivatives of 2-hydroxytetrahydrofuran and their use as medicaments |
06/10/2008 | US7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof |
06/10/2008 | CA2393995C Novel benzene sulfonamide derivatives, their preparation and pharmaceutical compositions containing them |
06/10/2008 | CA2326517C New galenic preparations of meloxicam for oral administration |
06/10/2008 | CA2129046C Opioid diarylmethylpiperazines and piperidines |
06/05/2008 | WO2008066145A1 Thiazole derivative and use thereof as vap-1 inhibitor |
06/05/2008 | WO2008066131A1 Novel phenyl-isoxazol-3-ol derivative |
06/05/2008 | WO2008065626A2 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors |
06/05/2008 | WO2008064789A1 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof |
06/05/2008 | WO2008064788A1 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof |
06/05/2008 | WO2008064474A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
06/05/2008 | WO2008033857A3 Substituted amides, method of making, and method of use thereof |
06/05/2008 | WO2008024765B1 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
06/05/2008 | WO2007115805A3 Aurora kinase inhibitors |
06/05/2008 | WO2007065288A3 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
06/05/2008 | US20080132562 Tetronic and tetramic acids |
06/05/2008 | US20080132551 Positive allosteric modulators of the nicotinic acetylcholine receptor |
06/05/2008 | US20080132547 (R)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2 -pyridinyl)methyl)sulfinyl)-1H-benzimidazole, (R(+)-lansoprazole); antiulcer agent |
06/05/2008 | US20080132546 e.g. Methyl 2-(6-{[(ethylamino)carbonyl]amino}pyridin-3-yl)-1,3-thiazole-5-carboxylate; bacterial DNA gyrase or bacterial topoisomerase IV inhibitor; antibacterial agent; antibiotic resistance; skin structure infections, pneumoniae, bronchitis, acute sinusitis, otitis media, sepsis, osteomyelitis |
06/05/2008 | US20080132542 [5-(5-{4-[2-(Trifluoromethyl)phenoxy]piperidin-1-yl}-1,3,4-thiadiazol-2-yl)-2H-tetrazol-2-yl]acetic acid; metabolic disorders,antidiabetic, hypoglycemic agent; obesity, insulin resistance, liver steatosis, atherosclerosis, neurological disease, dyslipidemia, hyperlipidemia, low HDL, and high LDL |
06/05/2008 | US20080132540 Such as trans-N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-N-(1-benzyl-piperidin-4-yl)-3-phenyl-acrylamide; for treating/preventing anxiolytic disorders/depression, injured mammalian nerve tissue, conditions, neurological disorders, bone loss, substance related disorders, and obesity; neuropeptide y (NPY Y2) |
06/05/2008 | US20080132523 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
06/05/2008 | US20080132513 new mechanism of action, oral bioavailability and/or reduced side effects; Ca2+-release-activated Ca2+ channels inhibitors; IL-2, IL-4, IL-5, IL-13, GM-CSF, TNF- alpha , and IFN gamma inhibitors; immunosuppressant |
06/05/2008 | US20080132506 Anti-inflammatory medicaments |
06/05/2008 | US20080132502 Phosphatidylinositol (PI) 3-kinase (PI3K); N-[5-(5-Benzylamino-6-chloropyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]acetamide, for example; anticancer agents, cardiovascular disorders, autoimmune disorders, rheumatic diseases |
06/05/2008 | US20080132496 Anticoagulants; factor Xa inhibitors; compounds are N-(benzimidazolyl, imidazo(4,5-b)pyridyl- or indolyl)-substituted benzamides |
06/05/2008 | US20080132495 Pyrazole Compounds that Modulate the Activity of Cdk, Gsk and Aurora Kinases |
06/05/2008 | US20080132494 Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
06/05/2008 | US20080132487 5-aminopyrazole derivatives as pesticidal compounds |
06/05/2008 | US20080132484 Screening for a modulator of Polio Like Kinase, designing and identifying small molecule inhibitors using a homology model for PLK |
06/05/2008 | US20080132483 Administering (3R,5S)-N-propanesulfonyl-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetamide; cerebral infarction |
06/05/2008 | US20080132481 Use of 3-substituted amino-2-carboxy-substituted indoles or benzo(b)thiophenes or esters thereof that modulate T helper (Th) cells; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and diseases associated with bacterial, rhinovirus or respiratory syncytial virus (RSV) infections |
06/05/2008 | US20080132479 Oxime Derivative and Preparations Thereof |
06/05/2008 | US20080132459 Inhibitors of Histone Deacetylase |
06/05/2008 | DE102006056740A1 Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung Cyclic substituted 3,5-dicyano-2-thiopyridines and their use |
06/05/2008 | DE102006056739A1 Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung Substituted 4-amino-3,5-dicyano-2-thiopyridines, and their use |
06/05/2008 | CA2669060A1 Piperidine compounds |
06/05/2008 | CA2668713A1 Novel phenyl-isoxazol-3-ol derivative |
06/04/2008 | EP1927594A1 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
06/04/2008 | EP1926826A2 Class iia histone deacetylase (hdac) substrate |
06/04/2008 | EP1926729A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands |
06/04/2008 | EP1926721A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
06/04/2008 | EP1926719A2 2-aniline-4-aryl substituted thiazole derivatives |
06/04/2008 | EP1926718A1 Pesticide thiazolyloxy substituted phenylamidine derivatives |
06/04/2008 | EP1926712A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
06/04/2008 | EP1926708A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
06/04/2008 | EP1841745B1 Process for the manufacture of a precursor of vitamin b1 |
06/04/2008 | EP1729723B1 Neutral and cationic naphthalene derivatives and dyes containing said compounds for dyeing keratin fibers |
06/04/2008 | EP1343775B1 Piperazine derivatives |
06/04/2008 | EP1237887B1 9-(piperazinylalkyl)carbazoles as bax-modulators |
06/04/2008 | EP1204643B1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
06/04/2008 | CN101193878A Agent for treatment of solid tumor |